IL-6 neutralizing antibodies can reverse the prolongation of Ca2 + transient duration and regional heterogeneity, reducing the incidence of discordant alternans, reducing the susceptibility and recurrence frequency of AF [94]. The gene discussed is IL6; the disease is atrial fibrillation.